Which group is responsible for monitoring the program's Estimated Performance Rates for quality measures each year?

The cancer committee plays a crucial role in monitoring the program's Estimated Performance Rates for quality measures each year. This committee is typically composed of diverse members, including healthcare professionals and administrators, who collaboratively assess the quality of care provided to cancer patients. By evaluating performance metrics, the cancer committee can identify areas of strength and opportunities for improvement, ensuring that the program adheres to established standards of care and effectively meets the needs of patients.

On an annual basis, the committee reviews data related to quality measures, which may include aspects such as treatment outcomes, patient satisfaction, and adherence to clinical guidelines. The insights gathered from this evaluation drive quality improvement initiatives, supporting the overall mission to enhance cancer care delivery.

While other groups, such as the Cancer Liaison Physician and Quality Improvement Coordinator, have important roles in communication and facilitating quality measures, it is the cancer committee that has the specific responsibility for ongoing monitoring and assessment, making it foundational to the program's commitment to quality care.